The 8 analysts offering 12-month price forecasts for NextCure Inc have a median target of 13.50, with a high estimate of 27.00 and a low estimate of 3.67. The median estimate represents a +201.34% increase from the last price of 4.48.
The current consensus among 8 polled investment analysts is to Buy stock in NextCure Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.72
Reporting Date Aug 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.